Regulation of Xanthine Oxidase Activity by Substrates at Active Sites via Cooperative Interactions between Catalytic Subunits: Implication to Drug Pharmacokinetics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|1|69-78

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.1, 2011-01, pp. : 69-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Metabolic Drug Interactions

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 5-20

Bentham Science Publishers

Access to resources Recommend Favorite

Augmenting the Xanthine Oxidase Inhibitory Activity of Febuxostat by its Structural Modification

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 2, 2014-02 ,pp. : 207-210

Bentham Science Publishers

Access to resources Recommend Favorite

Delavirdine: Clinical Pharmacokinetics and Drug Interactions

By Tran J.Q.  

Clinical Pharmacokinetics, Vol. 40, Iss. 3, 2001-01 ,pp. : 207-226

Adis International

Access to resources Recommend Favorite

Duloxetine: Clinical Pharmacokinetics and Drug Interactions

By >   Lobo Evelyn   Chappell Jill   Bergstrom Richard  

Clinical Pharmacokinetics, Vol. 50, Iss. 5, 2011-05 ,pp. : 281-294

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

By Khosravan Reza   Grabowski Brian A.   Wu Jing-Tao   Joseph-Ridge Nancy   Vernillet Laurent  

Clinical Pharmacokinetics, Vol. 45, Iss. 8, 2006-01 ,pp. : 821-841

Adis International

Access to resources Recommend Favorite